DOI:
10.1055/s-00000075
Seminars in Respiratory and Critical Care Medicine
LinksClose Window
References
Busse W, Buhl R, Fernandez Vidaurre C. , et al.
Omalizumab and the risk of malignancy: results from a pooled analysis.
J Allergy Clin Immunol 2012;
129 (04) 983-989.e6
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.